1. Clinical features of metastatic bone disease and risk of skeletal morbidity;Coleman;Clin Cancer Res,2006
2. Impact of skeletal complications on patients' quality of life, mobility, and functional independence;Costa;Support Care Cancer,2008
3. von Moos R, Henry D, Body JJ, Rider A, De Courcy J, Murray G, et al. Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer treated in real-world practice. In: 18th ECCO – 40th ESMO European cancer congress, Vienna, Austria 25–29 September 2015. p. 294.
4. Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study;Duran;Eur J Cancer Care (Engl),2017
5. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA);Hernlund;Arch Osteoporos,2013